# A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases

> **NCT06774664** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Sinocelltech Ltd.** · enrollment: 99 (estimated)

## Conditions studied

- IgA Nephropathy

## Interventions

- **BIOLOGICAL:** SCTC21C

## Key facts

- **NCT ID:** NCT06774664
- **Lead sponsor:** Sinocelltech Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01
- **Primary completion:** 2027-09
- **Final completion:** 2029-03
- **Target enrollment:** 99 (ESTIMATED)
- **Last updated:** 2025-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06774664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06774664, "A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06774664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*